Genetic Engineering Innovations - DNA-RNA Platforms GEG Tech

These past few months, cancer immunotherapy has sped-up thanks to CAR technology. One look at the recent news about this is enough to figure that out. As examples:
Two major deals between pharmaceutical companies and biotechs specialized in CAR T-cells: Gilead bought Kite Pharma for $12 billion, and Celgene bought Juno Therapeutics for $9 billion....

First-ever live tracking of HIV-1 based lentiviral vectors in human cells
Technology breakthrough: visualization of lentivirus genomes in living cells using ANCHOR technology.
We are proud to announce that we obtain great results through a collaborative project with NeoVirTech, a company developing auto fluorescent virus for imaging and screening applications. GEG Tech has validated the auto-fluorescent ANCHOR tagging of lentiviral...

The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes
In this article, Merienne et al. designed a smart lentiviral vector system to improve the safety for genome editing of CNS disease gene. They characterized their CRISPR self-inactivating system (KamiCas9) for permanent disruption of huntingtin gene in...

Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder resulting from a polyglutamine expansion in the huntingtin (HTT) protein. There is currently no cure for this disease, but recent studies suggest that RNAi to downregulate...